Catamenial epilepsy

Catamenial epilepsy is the seizure pattern correlated with specific phases of the menstrual cycle. It affects roughly 40% of women with epilepsy and is driven by cyclical hormone effects on neuronal excitability. The term comes from Greek "katamenios" meaning monthly.

This is informational, not medical advice. Epilepsy management requires specialist care. Talk to a neurologist or epileptologist for diagnosis and treatment, not to a general cycle syncing source.

The three patterns

Catamenial epilepsy is typically diagnosed when seizures cluster at least twofold higher in specific cycle windows compared to baseline. Three patterns are recognized:

  • C1 (perimenstrual): seizure increase from 3 days before menstruation through the first 3 days of bleeding. The most common pattern.
  • C2 (periovulatory): seizure increase around ovulation, typically days 10 to 13 of a 28-day cycle.
  • C3 (luteal): seizure increase throughout the entire luteal phase, particularly in anovulatory cycles where the progesterone surge does not occur normally.

Patterns may overlap. A person can have both C1 and C2 patterns.

The mechanism

The dominant model is the balance between estrogen (pro-excitatory) and progesterone and its metabolite allopregnanolone (anti-excitatory).

  • Estrogen enhances glutamate (excitatory) signaling and can lower seizure threshold.
  • Progesterone and allopregnanolone enhance GABA (inhibitory) signaling and raise seizure threshold.
  • The ratio of estrogen to progesterone, more than absolute levels, predicts seizure risk.

The patterns map onto this:

  • C1 (perimenstrual): sharp drop in both estrogen and progesterone. Allopregnanolone withdrawal removes the GABA-enhancing protection.
  • C2 (periovulatory): peak estrogen with relatively low progesterone. High excitatory tone.
  • C3 (luteal): in anovulatory cycles, low progesterone fails to provide its usual anti-excitatory effect across the whole luteal phase.

What the research supports

  • The pattern is well documented in approximately 40% of women with focal epilepsy and a smaller proportion with generalized epilepsy.
  • Prospective seizure diary tracking is needed to confirm the pattern (typically 3 months minimum).
  • Progesterone supplementation (specifically natural progesterone, not synthetic progestins) in luteal phase has supportive evidence for C3 pattern.
  • Some antiseizure medications may have altered pharmacokinetics across the cycle.
  • Combined hormonal contraceptives can interact with several antiseizure medications, reducing efficacy of one or the other.

Treatment approaches

Treatment for catamenial epilepsy is specialist-led. Common approaches include:

Conventional antiseizure medication adjustment:

  • Optimize baseline antiseizure medication
  • Increase doses around expected catamenial peak (under specialist guidance only)
  • Add a second medication during high-risk windows

Hormonal interventions:

  • Natural progesterone supplementation in luteal phase (for C3 pattern especially)
  • Combined hormonal contraceptives in some cases (with attention to drug interactions)
  • GnRH agonists for severe refractory cases

Other:

  • Acetazolamide (mild diuretic) around expected seizure window has some evidence
  • Sleep optimization (sleep deprivation is a major seizure trigger and overlaps with cyclical sleep disruption)
  • Stress management

Drug interactions to know

This is critical and not always communicated well:

  • Several enzyme-inducing antiseizure medications (carbamazepine, phenytoin, phenobarbital, primidone, oxcarbazepine, topiramate at higher doses) reduce hormonal contraceptive efficacy. A standard combined oral contraceptive can fail at usual doses.
  • Combined hormonal contraceptives can reduce lamotrigine levels significantly.
  • Newer antiseizure medications (levetiracetam, lacosamide) generally do not have these interactions.

Anyone with epilepsy on hormonal contraception, or considering it, needs explicit drug interaction review with their neurologist or epileptologist.

Catamenial epilepsy and cycle syncing

Cycle syncing as a general concept does not address epilepsy. Catamenial epilepsy management is medical, not lifestyle. That said, the practical phase-based scheduling principles can have safety relevance:

  • Anticipate seizure-cluster windows
  • Avoid sleep deprivation in those windows (sleep deficit is a known trigger)
  • Communicate the pattern to family or caregivers
  • Avoid driving or other safety-critical activities if seizures are not well controlled in known cluster windows (specifics depend on state or country regulations)

Seizure tracking apps and standard cycle tracking tools can support pattern identification.

When to talk to a provider

  • A neurologist or epileptologist should manage epilepsy diagnosis and treatment.
  • Suspected cyclical seizure pattern: request prospective tracking and discussion of catamenial management.
  • Any seizure pattern change: review with neurologist.
  • Considering hormonal contraception with epilepsy: review interactions explicitly.
  • Pregnancy planning with epilepsy: pre-conception specialist consultation is essential, as some antiseizure medications have teratogenic risk and folate requirements may be higher.
  • Worsening seizure control during perimenopause: hormonal shifts can change seizure patterns.